Picture this: You're doing your thing, enjoying life's moments, when suddenly outta nowhere, you're hit with a health scare. Maybe it's shortness of breath or unexplained fatigue. Maybe you feel dizzy or have chest pain.
At first, you brush it off, thinking it'll pass - but then it doesn’t. Soon, you seek medical help, only to find out you’ve got a condition you’ve never even heard of: ATTR-CM.
If you don’t know, Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare and potentially life-threatening condition, and it’s catching a lotta people off guard. Characterized by excessive and abnormal proteins in the heart, ATTR-CM may be a particular problem for Black folks.
According to recent studies, ATTR-CM is most common in older men of African descent, with about four percent of Black Americans carrying a gene mutation that makes them more likely to develop it.
Whether you have the condition and understand it well, or simply suspect you might be dealing with it, it’s never too late to understand the barriers.
Here are five challenges to be aware of - and then we’ll cover what we can do about ’em.
RELATED: ATTR-CM: Understanding This Rare But Serious Condition
1. People Simply Don’t Know
When it comes to ATTR-CM in the Black community, there’s just so little awareness. Heck, the acronym for the disease itself sounds like a computer code! ATTR-CM? What in the world is that?
Due to the general lack of education and recognition (and the fact that it only affects ~five in 100,000 people), it’s no wonder ATTR-CM flies under the radar. In certain urban communities, where healthcare literacy may be lower, opportunities for early intervention and treatment are often missed.
You May Also Like
2. Lack of Medical Attention
Not necessarily a fan of doctors? Don’t know who to trust or where to turn for culturally sensitive treatment? You’re not alone. In fact, it is well established in the literature that Black patients often struggle with a mistrust of the medical system, stemming from what some call a legacy of systemic racism and discrimination.
Some researchers also point to a tendency to deny or downplay pain and discomfort, a cultural phenomenon of pride and personal agency. Whatever the reason, these barriers can lead to a lack of health insurance and further hinder timely access to needed services.
3. Not Enough Specialized Diagnostics & Tests
It’s easy to confuse ATTR-CM with other heart-related conditions. That’s why having the right diagnostic tools, tests, and treatments is so critical. In certain Black communities, these specialized resources are simply missing. Advanced cardiac imaging, genetic testing, and tests like cardiac scintigraphy may not be readily available, leading to crucial delays in diagnosis.
Then you’ve got the cost. The financial burden can be significant if not covered by insurance. For instance, an endomyocardial biopsy can cost upwards of several thousand bucks. And that’s just one test!
4. Not Enough Clinical Trials
Clinical trials have a key role. They help advance our understanding of disease mechanisms, making it easier to evaluate potential treatments. However, Black folks are often underrepresented across the board, especially for rare conditions like ATTR-CM. Because of this, any clinical trial findings are hard to generalize. This, in turn, may worsen disparities in access to innovative therapies. In some cases, drugs may work wonders for one race but do little to nothing for another. Clearly, getting more Black patients in clinical trials is critical.
5. Money Money Money!
We already talked briefly about the financial burden of managing ATTR-CM, but it’s worth repeating. For people from low-income backgrounds with poor health insurance coverage, it’s especially difficult. Just think about it. You’ve got out-of-pocket expenses for appointments, medication costs, possible surgery expenses, and of course, potential lost wages due to illness. If you’re struggling with consistent employment or housing, it can be even more difficult.
The question is: how do we resolve these issues?
In the end, raising awareness about ATTR-CM comes down to two levels: societal and local. Societally, it’s all about healthcare providers, policymakers, and the general public. Because the condition is so rare, education campaigns are critical. Then there’s addressing systemic inequities in healthcare access. Government initiatives should strive to create strategies to improve access to quality care for all individuals, especially marginalized communities.
Meanwhile, locally, community-based interventions are also super important. Local providers, organizations, and especially faith-based groups can go a long way. Whether it’s education, screening, or just emotional support, Black individuals with ATTR-CM can get a lot outta their communities.
With a concerted push, increased awareness, and the right financial moves, culturally competent care is not just a possibility, it’s a likelihood.
